LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin
Colorectal cancer (CRC) is the third most prevalent tumor in men, the second most common in women, and the fourth leading cause of mortality worldwide. Statins reduce cholesterol levels by hampering the function of 3-hydroxy-3-methyl-glutaryl-CoA reductase enzymes in cholesterol synthesis. Strains h...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-01-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/138515/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841527724108152832 |
|---|---|
| author | Refat M. Nimer Hiba A. Nazazleh Belal A. Al-Husein Salah Abdelrazig Lina Elsalem Lina A. Dahabiyeh |
| author_facet | Refat M. Nimer Hiba A. Nazazleh Belal A. Al-Husein Salah Abdelrazig Lina Elsalem Lina A. Dahabiyeh |
| author_sort | Refat M. Nimer |
| collection | DOAJ |
| description | Colorectal cancer (CRC) is the third most prevalent tumor in men, the second most common in women, and the fourth leading cause of mortality worldwide. Statins reduce cholesterol levels by hampering the function of 3-hydroxy-3-methyl-glutaryl-CoA reductase enzymes in cholesterol synthesis. Strains have shown anticancer effects against CRC. However, statins’ anticancer mechanism is yet unknown. Liquid chromatography–mass spectrometry (LC–MS)-based untargeted metabolomics and proteomics were employed to study statins’ effects on CRC using the CRC cell line HCT-116. These approaches were utilized to identify potential underlying metabolic pathways and proteins altered in atorvastatin (a statin)-treated HCT-116 cells. Compared to the control, atorvastatin significantly altered numerous metabolites in HCT-116 cells, including a reduction in the levels of decanoylcarnitine and octanoyl-L-carnitine and in the biosynthesis and metabolism of amino acids like alanine and citrate cycle. Proteomic study showed that atorvastatin-treated HCT-116 cells expressed 127 proteins differently from controls. Novel findings were among them, such as centromere-associated protein E, cytochrome c oxidase subunit 6A1 mitochondrial, and hyaluronan synthase 1. The findings indicate that atorvastatin may have potential anticancer characteristics and highlight the essential role metabolomics and proteomics to understand complex metabolic pathways and proteins relevant to cancer and develop novel treatment targets. |
| format | Article |
| id | doaj-art-ffa2232fdaa643a381553aeecdbc3a6e |
| institution | Kabale University |
| issn | 2603-557X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Pensoft Publishers |
| record_format | Article |
| series | Pharmacia |
| spelling | doaj-art-ffa2232fdaa643a381553aeecdbc3a6e2025-01-15T08:30:54ZengPensoft PublishersPharmacia2603-557X2025-01-017211310.3897/pharmacia.72.e138515138515LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatinRefat M. Nimer0Hiba A. Nazazleh1Belal A. Al-Husein2Salah Abdelrazig3Lina Elsalem4Lina A. Dahabiyeh5Jordan University of Science and TechnologyJordan University of Science and TechnologyJordan University of Science and TechnologyNew York University Abu Dhabi (NYUAD)Jordan University of Science and TechnologyThe University of JordanColorectal cancer (CRC) is the third most prevalent tumor in men, the second most common in women, and the fourth leading cause of mortality worldwide. Statins reduce cholesterol levels by hampering the function of 3-hydroxy-3-methyl-glutaryl-CoA reductase enzymes in cholesterol synthesis. Strains have shown anticancer effects against CRC. However, statins’ anticancer mechanism is yet unknown. Liquid chromatography–mass spectrometry (LC–MS)-based untargeted metabolomics and proteomics were employed to study statins’ effects on CRC using the CRC cell line HCT-116. These approaches were utilized to identify potential underlying metabolic pathways and proteins altered in atorvastatin (a statin)-treated HCT-116 cells. Compared to the control, atorvastatin significantly altered numerous metabolites in HCT-116 cells, including a reduction in the levels of decanoylcarnitine and octanoyl-L-carnitine and in the biosynthesis and metabolism of amino acids like alanine and citrate cycle. Proteomic study showed that atorvastatin-treated HCT-116 cells expressed 127 proteins differently from controls. Novel findings were among them, such as centromere-associated protein E, cytochrome c oxidase subunit 6A1 mitochondrial, and hyaluronan synthase 1. The findings indicate that atorvastatin may have potential anticancer characteristics and highlight the essential role metabolomics and proteomics to understand complex metabolic pathways and proteins relevant to cancer and develop novel treatment targets.https://pharmacia.pensoft.net/article/138515/download/pdf/ |
| spellingShingle | Refat M. Nimer Hiba A. Nazazleh Belal A. Al-Husein Salah Abdelrazig Lina Elsalem Lina A. Dahabiyeh LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin Pharmacia |
| title | LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin |
| title_full | LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin |
| title_fullStr | LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin |
| title_full_unstemmed | LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin |
| title_short | LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin |
| title_sort | lc ms ms based proteomics and metabolomics of hct 116 colorectal cancer cells a potential anticancer activity of atorvastatin |
| url | https://pharmacia.pensoft.net/article/138515/download/pdf/ |
| work_keys_str_mv | AT refatmnimer lcmsmsbasedproteomicsandmetabolomicsofhct116colorectalcancercellsapotentialanticanceractivityofatorvastatin AT hibaanazazleh lcmsmsbasedproteomicsandmetabolomicsofhct116colorectalcancercellsapotentialanticanceractivityofatorvastatin AT belalaalhusein lcmsmsbasedproteomicsandmetabolomicsofhct116colorectalcancercellsapotentialanticanceractivityofatorvastatin AT salahabdelrazig lcmsmsbasedproteomicsandmetabolomicsofhct116colorectalcancercellsapotentialanticanceractivityofatorvastatin AT linaelsalem lcmsmsbasedproteomicsandmetabolomicsofhct116colorectalcancercellsapotentialanticanceractivityofatorvastatin AT linaadahabiyeh lcmsmsbasedproteomicsandmetabolomicsofhct116colorectalcancercellsapotentialanticanceractivityofatorvastatin |